|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.12 USD | -1.09% |
|
+5.83% | -28.69% |
| Capitalization | 7.42B 6.33B 5.91B 5.56B 10.23B 673B 11.18B 68.97B 26.75B 317B 27.86B 27.27B 1,157B | P/E ratio 2025 * |
15.6x | P/E ratio 2026 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise value | 11.68B 9.95B 9.29B 8.74B 16.1B 1,058B 17.58B 108B 42.07B 499B 43.81B 42.89B 1,819B | EV / Sales 2025 * |
1.32x | EV / Sales 2026 * | 1.32x |
| Free-Float |
51.55% | Yield 2025 * |
5.1% | Yield 2026 * | 5.25% |
Last Transcript: Eastman Chemical Company
| 1 day | -1.09% | ||
| 1 week | +5.83% | ||
| Current month | +4.90% | ||
| 1 month | +8.08% | ||
| 3 months | -3.04% | ||
| 6 months | -14.53% | ||
| Current year | -28.69% |
| 1 week | 60.2 |  | 66.1 |
| 1 month | 56.11 | | 66.1 |
| Current year | 56.11 | | 103.82 |
| 1 year | 56.11 | | 103.82 |
| 3 years | 56.11 | | 114.5 |
| 5 years | 56.11 | | 130.47 |
| 10 years | 34.44 | | 130.47 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Costa
CEO | Chief Executive Officer | 59 | 2013-12-31 |
William McLain
DFI | Director of Finance/CFO | 53 | 2020-02-27 |
Stephen Crawford
CTO | Chief Tech/Sci/R&D Officer | 61 | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Renée Hornbaker
BRD | Director/Board Member | 71 | 2003-08-31 |
Mark Costa
CHM | Chairman | 59 | 2014-06-29 |
Humberto Alfonso
BRD | Director/Board Member | 67 | 2011-01-03 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.79% | 624 M€ | +6.15% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.09% | +5.83% | -33.89% | -24.57% | 7.42B | |
| +0.87% | +1.51% | +5.36% | +75.22% | 74.66B | |
| +0.69% | -8.30% | -23.65% | +2.06% | 35.61B | |
| +0.28% | -0.31% | -30.00% | -33.69% | 32.21B | |
| -0.20% | +5.49% | +1.26% | +43.15% | 26.81B | |
| +1.25% | +7.46% | +74.29% | -26.83% | 18.8B | |
| -1.73% | -1.15% | +50.84% | +125.95% | 16.71B | |
| +1.39% | +0.55% | -11.82% | -15.81% | 16.12B | |
| -1.08% | +6.03% | +33.57% | -46.45% | 15.62B | |
| -0.23% | +7.52% | +32.79% | +14.47% | 13.33B | |
| Average | +0.01% | +2.11% | +9.88% | +11.35% | 25.73B | |
| Weighted average by Cap. | +0.32% | +1.16% | +5.41% | +24.84% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 8.83B 7.52B 7.03B 6.61B 12.17B 800B 13.29B 82B 31.81B 377B 33.12B 32.43B 1,375B | 8.89B 7.57B 7.07B 6.65B 12.25B 805B 13.38B 82.54B 32.02B 379B 33.34B 32.64B 1,384B |
| Net income | 486M 414M 386M 364M 669M 43.98B 731M 4.51B 1.75B 20.73B 1.82B 1.78B 75.64B | 701M 597M 558M 525M 967M 63.53B 1.06B 6.51B 2.53B 29.94B 2.63B 2.58B 109B |
| Net Debt | 4.25B 3.62B 3.38B 3.18B 5.86B 385B 6.4B 39.49B 15.32B 182B 15.95B 15.62B 662B | 4.33B 3.69B 3.44B 3.24B 5.96B 392B 6.51B 40.18B 15.59B 185B 16.23B 15.89B 674B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 65.12 $ | -1.09% | 2,200,499 |
| 25-12-11 | 65.84 $ | +1.35% | 2,138,316 |
| 25-12-10 | 64.96 $ | +6.13% | 2,018,540 |
| 25-12-09 | 61.21 $ | +1.32% | 2,096,172 |
| 25-12-08 | 60.41 $ | -1.82% | 1,708,290 |
Delayed Quote Nyse, December 12, 2025 at 04:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EMN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition